Clinical results for Episealer® accepted for presentation at the 19th ESSKA Congress
Episurf Medical (Nasdaq: EPIS B) today announces that an abstract with results from the European multicentre study with 24 months’ follow up of 75 Episealer® Knee patients has been accepted for presentation at the upcoming 19[th] ESSKA congress. The abstract, “Mini-metal implants - 2 year detailed cohort analysis of a patient specific implant“ is authored by Associate Professor Tim Spalding, University Hospitals Coventry and Warwickshire NHS Trust, UK. ESSKA (European Society for Sports Traumatology, Knee Surgery and Arthroscopy) is a European organisation focusing on